Literature DB >> 11264986

Very-low-density lipoprotein assembly and secretion.

G S Shelness1, J A Sellers.   

Abstract

The assembly of apolipoprotein B (apoB) into VLDL is broadly divided into two steps. The first involves transfer of lipid by the microsomal triglyceride transfer protein (MTP) to apoB during translation. The second involves fusion of apoB-containing precursor particles with triglyceride droplets to form mature VLDL. ApoB and MTP are homologs of the egg yolk storage protein, lipovitellin. Homodimerization surfaces in lipovitellin are reutilized in apoB and MTP to achieve apoB-MTP interactions necessary for first step assembly. Structural modeling predicts a small lipovitellin-like lipid binding cavity in MTP and a transient lipovitellin-like cavity in apoB important for nucleation of lipid sequestration. The formation of triglyceride droplets in the endoplasmic reticulum requires MTP however, their fusion with apoB may be MTP-independent. Second step assembly is modulated by phospholipase D and A2. Phospholipases may prime membrane transport steps required for second step fusion and/or channel phospholipids into a pathway for VLDL triglyceride production. The enzymology of VLDL triglyceride synthesis is still poorly understood; however, it appears that ACAT2 is the sole source of cholesterol esters for VLDL and chylomicron assembly. VLDL production is controlled primarily at the level of presecretory degradation. Recently, it was discovered that the LDL receptor modulates VLDL production through its interactions with nascent VLDL in the secretory pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264986     DOI: 10.1097/00041433-200104000-00008

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  62 in total

1.  Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan.

Authors:  Bard J Geesaman; Erica Benson; Stephanie J Brewster; Louis M Kunkel; Hélène Blanché; Gilles Thomas; Thomas T Perls; Mark J Daly; Annibale A Puca
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-13       Impact factor: 11.205

2.  Lipoproteins: When size really matters.

Authors:  J Bruce German; Jennifer T Smilowitz; Angela M Zivkovic
Journal:  Curr Opin Colloid Interface Sci       Date:  2006-06       Impact factor: 6.448

3.  Adaptation of enterocytic Caco-2 cells to glucose modulates triacylglycerol-rich lipoprotein secretion through triacylglycerol targeting into the endoplasmic reticulum lumen.

Authors:  Thomas Pauquai; Julien Bouchoux; Danielle Chateau; Romain Vidal; Monique Rousset; Jean Chambaz; Sylvie Demignot
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

Review 4.  The physiological role of triacylglycerol hydrolase in lipid metabolism.

Authors:  Dean Gilham; Richard Lehner
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

5.  Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B.

Authors:  Donald L Gillian-Daniel; Paul W Bates; Angie Tebon; Alan D Attie
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

6.  Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein.

Authors:  Richard G Lee; Wuxia Fu; Mark J Graham; Adam E Mullick; Donna Sipe; Danielle Gattis; Thomas A Bell; Sheri Booten; Rosanne M Crooke
Journal:  J Lipid Res       Date:  2012-12-06       Impact factor: 5.922

7.  Altered lipid droplet dynamics in hepatocytes lacking triacylglycerol hydrolase expression.

Authors:  Huajin Wang; Enhui Wei; Ariel D Quiroga; Xuejin Sun; Nicolas Touret; Richard Lehner
Journal:  Mol Biol Cell       Date:  2010-04-21       Impact factor: 4.138

8.  Lipid synthesis and secretion in HepG2 cells is not affected by ACTH.

Authors:  Maria Skoog; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2010-05-17       Impact factor: 3.876

9.  Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor.

Authors:  Emma M Allister; Erin E Mulvihill; P Hugh R Barrett; Jane Y Edwards; Lindsey P Carter; Murray W Huff
Journal:  J Lipid Res       Date:  2008-06-27       Impact factor: 5.922

10.  Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins.

Authors:  Vinca Icard; Olivier Diaz; Caroline Scholtes; Laure Perrin-Cocon; Christophe Ramière; Ralf Bartenschlager; Francois Penin; Vincent Lotteau; Patrice André
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.